Xiangdong Shi

Tacrolimus versus intravenous pulse cyclophosphamide therapy in Chinese adults with steroid-resistant idiopathic minimal change nephropathy: a multicenter, open-label, nonrandomized cohort trial.

Jianghua Chen, Hui-ping Wang, Hong Shen, 2012, Clinical therapeutics.